ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1728 National Cancer Institute Html en End-of-Life Care for People Who Have Cancer A fact sheet that answers some of the questions patients, their family members, and caregivers may have about the end of life.
family members0.618911
family caregivers0.218961
advance directives0.30098
patients0.4187
people0.36964
life0.365064
caregivers0.584429
health care team0.768547
person0.99495
patient0.848579
hospice care0.29663
Related Resources section0.284122
loved ones0.266236
cancer0.462571
CLICK HERE
1751 National Cancer Institute Html en Hospice Care A fact sheet about hospice care, including insurance coverage.
palliative care share0.4463
home health0.436046
hospice programs0.663338
hospice team0.740949
specific care decisions0.42786
hospice doctor0.624846
spiritual support0.408056
public health departments0.391127
American Cancer Society0.455655
hospice services0.722561
home health aides0.405139
state Medicaid office0.402126
nursing care0.391635
hospice medical director0.768439
Hospice Association0.649826
cancer care0.409838
hospital business office0.388593
life expectancy0.408587
hospice team member0.685192
special in-patient facilities0.500987
Medicare website0.415518
specific state locations0.392604
government health insurance0.402081
sheet Palliative Care0.444628
state social services0.40519
nursing homes0.407681
end-of-life care0.424373
health aide services0.410795
hospice organizations0.592662
Palliative Care Organization0.507564
private insurance plans0.399019
Hospice Net0.623257
palliative care0.604188
Medicare coverage0.386456
national hospice0.673933
regional home health0.398589
national hospice programs0.634262
hospice care0.982488
local state welfare0.391739
health insurance plans0.419219
Medicare benefits0.388255
hospice expenses0.700651
insurance plans0.503978
federal-state partnership program0.389089
Medicare Hospice Benefits0.695621
Medicare-certified hospice programs0.660409
Respite Care page0.429976
social work services0.407475
free fact sheets0.38648
CLICK HERE
1910 National Cancer Institute Html es Tratamiento de los tumores carcinoides gastrointestinales (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de los tumores carcinoides gastrointestinales.
tejido tumoral carcinoide0.303641
electrodos minúsculos0.300961
tumor carcinoide0.379006
siguientes procedimientos0.32226
pequeña cámara0.300969
pequeña cantidad0.300995
claro cuál0.301673
rayos x0.301155
tumores carcinoides gi0.541315
cromogranina a0.301286
ondas sonoras0.301178
síndrome carcinoide0.405552
pequeño efecto0.300747
tumores neuroendocrinos0.31718
National Cancer Institute0.300501
tumores carcinoide gi0.305034
siguientes riesgos0.300555
endocrina múltiple tipo0.30275
Instituto Nacional0.300956
PDQ Tratamiento0.301284
neurofibromatosis tipo0.301611
tubo gi0.311684
Physician Data Query0.302032
pimientos chili0.300797
carcinoides gi recidivantes0.302839
Antecedentes familiares0.301159
cuerpo cantidades0.303122
hígado ayuda0.301344
tumores carcinoides0.989957
tumor carcinoide gi0.311705
siguientes sumarios0.303432
células neuroendocrinas0.30282
CLICK HERE
1967 National Cancer Institute Html es Tratamiento del cáncer de pene (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de pene.
siguientes procedimientos0.765966
siguientes aspectos0.663436
radiosensibilizadores ayuda0.608332
estadio ii0.653561
ganglio linfático centinela0.99757
rayos x0.61452
menor cantidad0.630187
enlace drugs approved0.616023
ondas sonoras0.614903
National Cancer Institute0.60451
siguientes riesgos0.604706
papiloma virus0.656514
únicos tratamientos0.60726
Instituto Nacional0.609778
Penile Cancer0.60882
estadio iiia0.623114
PDQ Tratamiento0.608893
cuerpo esponjoso0.725663
presente sección0.608144
Physician Data Query0.620917
siguientes sitios0.675658
siguientes operaciones0.617884
órgano masculino0.616691
siguientes pruebas0.65372
siguientes estadios0.621615
CLICK HERE
2080 National Cancer Institute Html es Exámenes de detección del cáncer de testículo (PDQ®)–Versión para pacientes Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de testículo.
estadios tardíos0.651471
Visuals Online0.570773
PDQ Exámenes0.759721
Physician Data Query0.918778
testículos.ampliar anatomía0.643812
mejores tratamientos0.631067
prevención revisa0.590052
sistema urinario masculino0.76274
glándulas sexuales masculinas0.790025
información ayuda0.600632
National Cancer Institute0.62598
siguientes riesgos0.575127
Instituto Nacional0.738066
CLICK HERE
3427 National Cancer Institute Html es Terapia láser para el tratamiento del cáncer Hoja informativa que describe el uso de una luz de alta intensidad en el tratamiento del cáncer, sus ventajas y desventajas, y los tipos de procedimientos que la utilizan.
usa calor0.497681
luz solar0.504529
terapia láser usa0.846675
usa rayos0.615014
sustancia fotosensibilizadora0.467924
alta intensidad0.607112
terapia láser causa0.851667
áreas minúsculas0.473045
determinados síntomas0.470796
CLICK HERE
3599 National Cancer Institute Html en The RAS Initiative NCI established the RAS Initiative to explore innovative approaches for attacking the proteins encoded by mutant forms of RAS genes and to ultimately create effective, new therapies for RAS-related cancers.
new therapies0.393067
RAS0.99043
RAS family0.739708
long way0.387894
oncogenic RAS0.6688
primary focus0.382845
RAS problem0.663793
industry0.314692
videos0.313651
mouse retroviruses0.388906
lab0.314136
percent0.362189
online forum RAS0.726513
RAS reagents0.661904
Douglas R. Lowy0.440325
RAS genes0.803577
Varmus’s vision0.381489
RAS hub0.667188
entire field0.379292
mutations0.318554
RAS oncogenes0.710337
proteins0.316387
Dear Colleagues0.397967
National Cancer Institute0.440589
pancreatic cancers0.432526
NCI director0.401396
RAS-related cancers0.425588
events0.31366
group0.314948
innovative approaches0.393563
goal0.328772
biology0.314898
academic researchers0.385896
RAS Central0.733488
virtual network0.380109
headway0.320561
Dr. Harold Varmus0.45561
blog posts0.37846
ras initiative0.905093
mutant forms0.396413
scientists0.313674
useful tools0.379773
human cancers0.42887
fascinating problem0.378178
colorectal cancers0.432751
concerted effort0.392419
time0.314762
CLICK HERE
3880 National Cancer Institute Html es Extractos de muérdago (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos sobre el uso de los extractos de muérdago como tratamiento para personas con cáncer.
from mistletoe extract0.31162
Cancer Res Clin0.306787
mistletoe extracts0.396569
album extract isorel0.309539
Mistletoe extracts standardised0.30709
viscum album0.980886
galactoside-specific lectin from0.335383
thionins from viscum0.3152
muérdago i0.308032
treated with viscum0.312029
Cancer Res0.31513
isolated from viscum0.307496
extracto viscum album0.308065
Viscum album agglutinin-induced0.308373
with viscum album0.33586
from viscum album0.472392
beta-galactoside-specific lectin from0.310754
Hajto T0.314595
extract from viscum0.316835
Viscum album enhancing0.30854
patients with0.307472
thionins from european0.306901
Immunomodulatory Agents from0.306741
viscum album extract0.338924
viscum album l0.601922
Mistletoe lectins as0.306952
preparation from viscum0.308802
Complement Ther Med0.308742
tumor cell0.31334
Mistletoe extracts standardized0.30726
Beuth J0.317637
mistletoe treatment0.310143
lectin from0.350339
derived from viscum0.315008
In vitro effects0.312037
Schaller G0.307482
blood mononuclear cells0.315901
subspecies viscum album0.308835
lectin from viscum0.322905
Gabius HJ0.329931
Viscum album induces0.316269
ml1 from viscum0.307567
breast cancer0.326075
Viscum album species0.308916
plant lectin0.306716
mistletoe lectins0.449053
in vitro0.456679
Hostanska K0.309958
fermented extract from0.30821
CLICK HERE
15645 National Cancer Institute Html en Legal Requirements Research grants are subject to many requirements from a variety of legal authorities, with the broadest being the U.S. Constitution.
Grants Management Officer0.556816
United States Code0.420323
research grants0.615532
basic substantive legislation0.444546
program requirements0.352641
to-date policy guidance0.408228
general regulations0.340444
federal agency0.352362
federal regulations0.501493
Administrative Procedures Act0.389735
NIH standard terms0.534403
NIH Grants Policy0.868204
research grant policies0.404926
reasonable conditions0.340026
research community0.390073
appropriation legislation0.37075
individual grants0.462407
Appropriation bills0.343865
NIH contracting offices0.525598
legal authorities0.328189
issues government-wide circulars0.425727
administrative requirements0.328069
NCI grants0.592028
human subjects protection0.399778
grants administration policies0.567751
Congress0.346023
authorize federal agencies0.500849
United States0.452601
CFR Parts0.368971
grants administration decisions0.591481
federal Executive agencies0.452185
CFR0.384291
appropriation laws0.351099
Spending Power Clause0.442228
United States Constitution0.43014
grants administration0.689773
grants area0.524071
appropriate NIH oversight0.528865
grants0.962134
program expenditures0.33855
requirements0.388492
NIH Guide0.647123
federal register0.490568
federal assistance funds0.682098
specific laws0.335616
specific program0.335203
federal program0.371737
Public Health Service0.421913
general authority0.329535
CLICK HERE
16162 National Cancer Institute Html en New Therapies Are Changing the Outlook for Advanced Melanoma An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.
improved progression-free survival0.366558
new therapies0.351845
target BRAF proteins0.357172
commonly used therapies0.342946
BRAF inhibitor0.43187
BRAF mutations0.802264
Cancer Therapy Evaluation0.357896
Overall survival results0.381093
Dr. Schuchter0.658164
overall survival0.53856
clinical trials0.561097
results0.412771
median progression-free survival0.364224
clinical trial0.629151
median overall survival0.359384
patients0.941423
recent FDA-approved drugs0.349384
tumor responses0.376799
metastatic melanoma0.378989
chemotherapy drug dacarbazine0.34213
median survival0.400006
melanoma specialist0.389264
large clinical trial0.469476
MEK inhibitor0.413513
cancer cells0.348742
Patient tumor samples0.353483
skin-related side effects0.386676
MEK inhibitor cobimetinib0.40543
clinical trial participants0.357541
BRAF-MEK inhibitor combination0.3755
Dr. Streicher0.487979
tumor cells0.429743
checkpoint inhibitor0.371337
small clinical trials0.342687
drugs0.41439
progression-free survival0.707667
MEK inhibitors0.605005
advanced melanoma0.87481
PD-1 inhibitor0.342866
recent clinical trials0.345485
new treatment options0.457424
tumors0.426135
New Melanoma Therapies0.48664
early-phase clinical trial0.367414
Moffitt Cancer Center0.358773
regulatory approval0.407964
Pennsylvania Abramson Cancer0.343564
skin cancer melanoma0.49678
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.